Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.
Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, Simakova TS, Vasilyev KA, Shurygina AP, Stukova MA, Safina KR, Nabieva ER, Garushyants SK, Klink GV, Bakin EA, Zabutova JV, Kholodnaia AN, Lukina OV, Skorokhod IA, Ryabchikova VV, Medvedeva NV, Lioznov DA, Danilenko DM, Chudakov DM, Komissarov AB, Bazykin GA. Stanevich OV, et al. Among authors: stukova ma. Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x. Nat Commun. 2023. PMID: 36627290 Free PMC article.
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Kudriavtsev AV, Vakhrusheva AV, Kryuchkov NA, Frolova ME, Blagodatskikh KA, Ivanishin TV, Djonovic M, Romanovskaya-Romanko EA, Kovalenko AN, Lioznov DA, Zubkova TG, Teplykh SV, Oseshnyuk RA, Stukova MA, Isaev AA, Krasilnikov IV. Kudriavtsev AV, et al. Among authors: stukova ma. Vaccines (Basel). 2023 Feb 1;11(2):326. doi: 10.3390/vaccines11020326. Vaccines (Basel). 2023. PMID: 36851204 Free PMC article.
Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2.
Vasin AV, Stukova MA. Vasin AV, et al. Among authors: stukova ma. Lancet Infect Dis. 2023 Aug;23(8):880-881. doi: 10.1016/S1473-3099(23)00189-5. Epub 2023 Apr 21. Lancet Infect Dis. 2023. PMID: 37088097 Free PMC article. No abstract available.
Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine, Against Various Strains of SARS-CoV-2.
Vakhrusheva AV, Romanovskaya-Romanko EA, Stukova MA, Sukhova MM, Kuznetsova KS, Kudriavtsev AV, Frolova ME, Ivanishin TV, Krasilnikov IV, Isaev AA. Vakhrusheva AV, et al. Among authors: stukova ma. Vaccines (Basel). 2024 Oct 21;12(10):1200. doi: 10.3390/vaccines12101200. Vaccines (Basel). 2024. PMID: 39460365 Free PMC article.
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-Romanko EA, Stukova MA, Isaev AA, Krasilnikov IV. Vakhrusheva AV, et al. Among authors: stukova ma. Vaccines (Basel). 2022 Aug 10;10(8):1290. doi: 10.3390/vaccines10081290. Vaccines (Basel). 2022. PMID: 36016181 Free PMC article.
28 results